These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overshadowing and salience attribution in relation to cannabis use. Dawes C; McGreal SJ; Marwaha S; Prados J; Reheis A; Dumitrescu A; Waddington JL; Moran PM; O'Tuathaigh C Schizophr Res Cogn; 2024 Sep; 37():100315. PubMed ID: 38764742 [TBL] [Abstract][Full Text] [Related]
5. Tracking salience in young people: A psychometric field test of the Aberrant Salience Inventory (ASI). Raballo A; Cicero DC; Kerns JG; Sanna S; Pintus M; Agartz I; Pintus E; Corrias I; Lai V; Petretto DR; Carta MG; Preti A Early Interv Psychiatry; 2019 Feb; 13(1):64-72. PubMed ID: 28719056 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Salience among Young Healthy Postgraduate University Students: The Role of Cannabis Use, Psychotic-Like Experiences, and Personality. Patti A; Santarelli G; D'Anna G; Ballerini A; Ricca V Psychopathology; 2022; 55(2):116-122. PubMed ID: 35016193 [TBL] [Abstract][Full Text] [Related]
7. Cannabis users differ from non-users on measures of personality and schizotypy. Fridberg DJ; Vollmer JM; O'Donnell BF; Skosnik PD Psychiatry Res; 2011 Mar; 186(1):46-52. PubMed ID: 20813412 [TBL] [Abstract][Full Text] [Related]
8. The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample. Soler J; Arias B; Moya J; Ibáñez MI; Ortet G; Fañanás L; Fatjó-Vilas M Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():174-180. PubMed ID: 30118824 [TBL] [Abstract][Full Text] [Related]
9. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders. Pugliese V; de Filippis R; Aloi M; Rotella P; Carbone EA; Gaetano R; De Fazio P Ann Gen Psychiatry; 2022 Jul; 21(1):25. PubMed ID: 35786401 [TBL] [Abstract][Full Text] [Related]
10. Aberrant Salience Across Levels of Processing in Positive and Negative Schizotypy. Chun CA; Brugger P; Kwapil TR Front Psychol; 2019; 10():2073. PubMed ID: 31620045 [TBL] [Abstract][Full Text] [Related]
11. [Schizotypal Personality Questionnaire-Brief - Likert format: Factor structure analysis in general population in France]. Ferchiou A; Todorov L; Lajnef M; Baudin G; Pignon B; Richard JR; Leboyer M; Szöke A; Schürhoff F Encephale; 2017 Dec; 43(6):558-563. PubMed ID: 27644915 [TBL] [Abstract][Full Text] [Related]
12. Aberrant salience predicts psychotic-like experiences in daily life: An experience sampling study. Chun C; Gross G; Mielock A; Kwapil T Schizophr Res; 2020 Jun; 220():218-224. PubMed ID: 32249121 [TBL] [Abstract][Full Text] [Related]
13. Psychometric investigation of the French version of the Aberrant Salience Inventory (ASI): differentiating patients with psychosis, patients with other psychiatric diagnoses and non-clinical participants. Golay P; Laloyaux J; Moga M; Della Libera C; Larøi F; Bonsack C Ann Gen Psychiatry; 2020; 19():58. PubMed ID: 33024446 [TBL] [Abstract][Full Text] [Related]
14. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users. Cohen K; Rosenzweig S; Rosca P; Pinhasov A; Weizman A; Weinstein A Front Psychiatry; 2020; 11():355. PubMed ID: 32477173 [TBL] [Abstract][Full Text] [Related]
15. Cannabis Use, Psychotic Like Experiences and Aberrant Salience in a Sample of Belgian Students. Bernardini F; Gobbicchi C; Attademo L; Puchalski S; Trezzi R; Moretti P; Tortorella A; Loas G J Nerv Ment Dis; 2018 Jul; 206(7):493-500. PubMed ID: 29965876 [TBL] [Abstract][Full Text] [Related]
16. Cannabis's Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion? Altman BR; Earleywine M; Mian MN; Dalal DK Cannabis; 2022; 5(2):28-39. PubMed ID: 37287953 [TBL] [Abstract][Full Text] [Related]
17. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders. Pugliese V; de Filippis R; Aloi M; Carbone EA; Rania M; Segura-Garcia C; De Fazio P Span J Psychiatry Ment Health; 2024; 17(3):154-159. PubMed ID: 38570903 [TBL] [Abstract][Full Text] [Related]
18. Is there a common vulnerability in cannabis phenomenology and schizotypy? The role of the N170 ERP. Brooks GA; Brenner CA Schizophr Res; 2018 Jul; 197():444-450. PubMed ID: 29174334 [TBL] [Abstract][Full Text] [Related]
19. Patterns of cannabis use, psychotic-like experiences and personality styles in young cannabis users. Spriggens L; Hides L Schizophr Res; 2015 Jun; 165(1):3-8. PubMed ID: 25868934 [TBL] [Abstract][Full Text] [Related]
20. Salience attribution and its relationship to cannabis-induced psychotic symptoms. Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]